Company
Abingdon Health PLC
LON:ABDX
Abingdon Health is a leading lateral flow contract research (CRO) and contract development and manufacturing organisation ("CDMO") offering its services to an international customer base across industry sectors that include clinical, animal health, plant health, and environmental testing.
16 stories
Abingdon Health climbs after forecasting 'materially higher' 2023 revenue
Abingdon health was up 13% on Tuesday after forecasting 2023 revenues would be "materially higher"
Abingdon Health says ‘pleased’ with High Court dismissal of challenge to UK government’s lateral flow test contracts
"At Abingdon Health we answered the government's call for leading UK life sciences companies to respond quickly with solutions to help during the height of the pandemic. We did the right thing," said the company's CEO Chris Yates
Abingdon Health signs contract for lateral flow component manufacturing
The contract is for an initial 12-month period with an option to extend and is worth at least £2.7mln in the first year
Archive
CML Microsystems says trading ahead of market expectations
A look at the major movers on the London market on Tuesday
Small cap movers: Abingdon Health and MyHealthChecked reap rewards from the fight against COV ID-19
A look at some of the major movers in the small caps universe this week
Poolbeg Pharma perks up after weekend press commentary
The test uses a fraction of a drop of finger-prick blood with results in 20 minutes